Philip Grunert

544 total citations
25 papers, 338 citations indexed

About

Philip Grunert is a scholar working on Epidemiology, Genetics and Infectious Diseases. According to data from OpenAlex, Philip Grunert has authored 25 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Genetics and 7 papers in Infectious Diseases. Recurrent topics in Philip Grunert's work include Inflammatory Bowel Disease (9 papers), Microscopic Colitis (9 papers) and Clostridium difficile and Clostridium perfringens research (5 papers). Philip Grunert is often cited by papers focused on Inflammatory Bowel Disease (9 papers), Microscopic Colitis (9 papers) and Clostridium difficile and Clostridium perfringens research (5 papers). Philip Grunert collaborates with scholars based in Germany, Netherlands and Belgium. Philip Grunert's co-authors include Andreas Stallmach, Philipp A. Reuken, Johannes Stallhofer, Niels Teich, Carsten Schmidt, Yukun Su, Rainer Bader, Anika Jonitz‐Heincke, Doris Hansmann and Thomas Kamradt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and Analytical Chemistry.

In The Last Decade

Philip Grunert

24 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Grunert Germany 11 101 99 71 55 52 25 338
Carmen Martín Carreras‐Presas Spain 8 114 1.1× 21 0.2× 157 2.2× 35 0.6× 53 1.0× 24 794
Emilia Barreto-Durán Poland 9 158 1.6× 15 0.2× 83 1.2× 23 0.4× 19 0.4× 14 347
Amira Yasmine Benmelouka Egypt 11 74 0.7× 33 0.3× 57 0.8× 38 0.7× 50 1.0× 26 344
Lauren A. Vaught United States 12 170 1.7× 29 0.3× 109 1.5× 35 0.6× 65 1.3× 23 433
Krishna Patel United States 9 112 1.1× 43 0.4× 141 2.0× 34 0.6× 172 3.3× 24 448
Nishant Singh India 15 152 1.5× 23 0.2× 241 3.4× 54 1.0× 47 0.9× 42 560
Sanjay Chauhan India 12 62 0.6× 25 0.3× 111 1.6× 44 0.8× 24 0.5× 53 548
Hongye Jiang China 11 90 0.9× 29 0.3× 143 2.0× 81 1.5× 27 0.5× 29 479
Soham Mukherjee India 12 84 0.8× 62 0.6× 53 0.7× 26 0.5× 67 1.3× 52 433
Marleen M. Welsh United States 9 25 0.2× 69 0.7× 88 1.2× 104 1.9× 57 1.1× 11 358

Countries citing papers authored by Philip Grunert

Since Specialization
Citations

This map shows the geographic impact of Philip Grunert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Grunert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Grunert more than expected).

Fields of papers citing papers by Philip Grunert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Grunert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Grunert. The network helps show where Philip Grunert may publish in the future.

Co-authorship network of co-authors of Philip Grunert

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Grunert. A scholar is included among the top collaborators of Philip Grunert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Grunert. Philip Grunert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conrad, Claudio, Mark Ellrichmann, Michiel Bronswijk, et al.. (2025). Long‐Term Efficacy and Safety of Digital‐Single‐Operator‐Video‐Pancreatoscopy Guided Lithotripsy for Pancreatic Duct Stones. United European Gastroenterology Journal. 13(7). 1127–1132.
2.
Baumgart, Daniel C., Andreas Stallmach, Philip Grunert, et al.. (2024). Induction and maintenance of mucosal healing in Crohn’s disease with ustekinumab in clinical practice across all care levels in Germany (MUCUS). Scientific Reports. 14(1). 20502–20502. 1 indexed citations
3.
Stallhofer, Johannes, et al.. (2023). Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease. International Journal of Colorectal Disease. 38(1). 54–54. 9 indexed citations
4.
Rao, Zhigang, Benjamin Giszas, Aishwarya Iyer, et al.. (2023). Glucocorticoids regulate lipid mediator networks by reciprocal modulation of 15-lipoxygenase isoforms affecting inflammation resolution. Proceedings of the National Academy of Sciences. 120(35). e2302070120–e2302070120. 12 indexed citations
5.
Cseresnyés, Zoltán, Philip Grunert, Stephanie Hoeppener, et al.. (2023). Selective Uptake Into Inflamed Human Intestinal Tissue and Immune Cell Targeting by Wormlike Polymer Micelles. Small. 20(21). e2306482–e2306482. 5 indexed citations
7.
Stallmach, Andreas, et al.. (2023). Treatment strategies in inflammatory bowel diseases. Deutsches Ärzteblatt international. 120(45). 768–778. 19 indexed citations
8.
Stallmach, Andreas, et al.. (2022). Fäkaler Mikrobiomtransfer – Indikationen, Risiken und Chancen. Die Innere Medizin. 63(10). 1036–1042. 1 indexed citations
10.
Stallmach, Andreas, et al.. (2021). The COVID-19 Pandemic: Fears and Overprotection in Pediatric Patients with Inflammatory Bowel Disease and Their Families. Pediatric Gastroenterology Hepatology & Nutrition. 24(1). 65–65. 10 indexed citations
11.
Reuken, Philipp A., et al.. (2021). T Cell Response After SARS-CoV-2 Vaccination in Immunocompromised Patients with Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 16(2). 251–258. 33 indexed citations
12.
Schmidt, Carsten, Philip Grunert, & Andreas Stallmach. (2021). An Update for Pharmacologists on New Treatment Options for Inflammatory Bowel Disease: The Clinicians’ Perspective. Frontiers in Pharmacology. 12. 655054–655054. 20 indexed citations
13.
Reuken, Philipp A., Philip Grunert, Andreas Lügering, Niels Teich, & Andreas Stallmach. (2020). Self-assessment of treatment targets in patients with inflammatory bowel disease using a survey. Therapeutic Advances in Gastroenterology. 13. 3974160077–3974160077. 3 indexed citations
14.
Vieth, Michael, et al.. (2020). Towards an Interpretable Classifier for Characterization of Endoscopic Mayo Scores in Ulcerative Colitis Using Raman Spectroscopy. Analytical Chemistry. 92(20). 13776–13784. 34 indexed citations
15.
Stallmach, Andreas, et al.. (2020). Fecal Microbiota Transfer. Deutsches Ärzteblatt international. 117(3). 31–38. 18 indexed citations
16.
Stallmach, Andreas, et al.. (2020). Fecal Microbiota Transfer Reliable Indications, Donor Screening, and Modes of Application. Kölner Universitäts PublikationsServer (Universität zu Köln). 2 indexed citations
17.
Hoyer, Heike, et al.. (2019). Fatigue bei Patienten mit chronisch entzündlichen Darmerkrankungen (CED): häufig und durch Laboruntersuchungen nicht zu erkennen!. Zeitschrift für Gastroenterologie. 2 indexed citations
18.
Jonitz‐Heincke, Anika, et al.. (2016). Magnetically induced electrostimulation of human osteoblasts results in enhanced cell viability and osteogenic differentiation. International Journal of Molecular Medicine. 38(1). 57–64. 27 indexed citations
19.
Prager, Matthias, Janine Büttner, Philip Grunert, David Ellinghaus, & Carsten Büning. (2016). A Promoter Variant Within the Aryl Hydrocarbon Receptor Gene Is Associated with an Epithelial Barrier Defect in Smokers with Crohnʼs Disease. Inflammatory Bowel Diseases. 22(10). 2356–2368. 10 indexed citations
20.
Grunert, Philip, Anika Jonitz‐Heincke, Yukun Su, et al.. (2014). Establishment of a Novel In Vitro Test Setup for Electric and Magnetic Stimulation of Human Osteoblasts. Cell Biochemistry and Biophysics. 70(2). 805–817. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026